0001062993-20-000108.txt : 20200110
0001062993-20-000108.hdr.sgml : 20200110
20200110194152
ACCESSION NUMBER: 0001062993-20-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200106
FILED AS OF DATE: 20200110
DATE AS OF CHANGE: 20200110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUTCHISON PATRICK
CENTRAL INDEX KEY: 0001673870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 20522333
MAIL ADDRESS:
STREET 1: C/O BIOSPECIFICS TECHNOLOGIES CORP
STREET 2: 2 RIGHTER PARKWAY SUITE 200
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER NAME:
FORMER CONFORMED NAME: Hutchison Patrick
DATE OF NAME CHANGE: 20160504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-01-06
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001673870
HUTCHISON PATRICK
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
56.21
2020-01-06
4
A
0
10000
0.00
A
2030-01-06
Common Stock
10000
10000
D
The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. This transaction is reported late due to delayed receipt of the Reporting Person's EDGAR access codes.
The stock options vest ratably over the four-year period following the date of grant, January 6, 2020, subject to the Reporting Person's continued service to the employer through the vesting date.
/s/ Patrick C. Hutchison, by Carl A. Valenstein, attorney-in-fact
2020-01-10